Printer Friendly

CROP GENETICS INTERNATIONAL REPORTS RESULTS FOR QUARTER ENDED MARCH 31, 1992

 CROP GENETICS INTERNATIONAL REPORTS RESULTS
 FOR QUARTER ENDED MARCH 31, 1992
 HANOVER, Md., May 12 /PRNewswire/ -- Crop Genetics International (NASDAQ: CROP) today reported revenues of $620,400 for the quarter ended March 31, 1992 compared to $601,800 in the same quarter last year. Net loss was $1,652,900 or $.43 per share, compared to a net loss of $1,445,700 or $.45 per share in the same quarter of last year.
 Crop Genetics International Corporation is engaged in the discovery, development and commercialization of novel crop protection systems which substitute biopesticides for synthetic chemicals. The company's Instar (TM) Division, in cooperation with E.I. DuPont de Nemours & Co., is developing insecticidal virus products to control a range of insect pests on major crops. The InCide (R) Division is developing plant vaccine systems in which plant seeds are inoculated with genetically engineered microorganisms to provide season-long and environmentally compatible pest control. The X-tend (TM) Division is developing bacterial agents for use in combination with reduced amounts of chemical herbicides to control a broad range of weed species. The Kleentek (R) Division has developed and now markets disease-free, high yielding sugarcane seed products.
 CROP GENETICS INTERNATIONAL CORPORATION
 Condensed Statements of Operations
 Three months ended
 March 31 1992 1991
 Revenues:
 Research revenue $437,500 $100,000
 Investment income 162,700 501,200
 Other 20,200 600
 Total revenues 620,400 601,800
 Costs and expenses:
 Field management 117,100 95,800
 Research and development 1,653,500 1,534,100
 General and administrative 464,000 417,600
 Acquired technology 38,700 --
 Total costs and expenses 2,273,300 2,047,500
 Net loss (1,652,900) (1,445,700)
 Preferred stock dividends 640,100 641,300
 Net loss applicable
 to com. shares (2,293,000) (2,087,000)
 Net loss per common share (0.43) (0.45)
 Avg. no. of com.
 shares outstdg. 5,363,128 4,685,497
 Condensed Balance Sheets
 3/31/92 12/31/91
 Current Assets
 Cash and short-item
 investments $18,274,700 $19,378,600
 Other current assets 1,053,900 1,158,800
 Total current assets 19,328,900 20,537,400
 Fixes assets (net) 2,360,400 2,530,800
 Total 21,689,000 23,068,200
 Current Liabilities 1,027,200 451,800
 Common and preferred
 stockholders' equity 20,661,800 22,616,400
 Total 21,689,000 23,068,200
 -0- 5/12/92
 /CONTACT: Jolane Furr of Crop Genetics International, 410-712-7170, or Noonan/Russo Communications, Inc., 212-979-9180, for Crop Genetics/
 (CROP) CO: Crop Genetics International ST: Maryland IN: CHM SU: ERN


KD-AH -- NY106 -- 9381 05/12/92 17:41 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 12, 1992
Words:440
Previous Article:STANDARD & POOR'S STOCK PRICE INDEX -- CLOSING, TUESDAY, MAY 12
Next Article:BIOSYS REPORTS FIRST QUARTER RESULTS
Topics:


Related Articles
CROP GENETICS REPORTS IMPROVED CONTROL WITH CORN BIOINSECTICIDE
DEKALB AND CROP GENETICS MODIFY AGREEMENT
MORTON INTERNATIONAL REPORTS RECORD THIRD QUARTER
DR. ALAN HAYES JOINS CROP GENETICS BOARD OF DIRECTORS
CROP GENETICS INTERNATIONAL REPORTS RESULTS FOR QUARTER ENDING MARCH 31, 1993
CROP GENETICS INTERNATIONAL RECEIVES EPA REGISTRATION
CROP GENETICS INTERNATIONAL CANCELS MARKETING AGREEMENT
BIOSYS INC. ANNOUNCES FOURTH QUARTER RESULTS
Paradigm Genetics and Bayer AG Extend Commercial Partnership On Herbicides for Additional Five Years.
DuPont Collaborates with Japan Tobacco Inc. for Development of Corn and Soybean Yield Traits.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters